FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1932574503> ?p ?o ?g. }

• W1932574503 endingPage "3767" @default.
• W1932574503 startingPage "3758" @default.
• W1932574503 abstract "The efficacy and tolerability of anastrozole (Arimidex; AstraZeneca, Wilmington, DE, and Macclesfield, United Kingdom) and tamoxifen were compared as first-line therapy for advanced breast cancer in 353 postmenopausal women.The randomized, double-blind, multicenter study was designed to evaluate anastrozole 1 mg once daily relative to tamoxifen 20 mg once daily in patients with hormone receptor-positive tumors or tumors of unknown receptor status who were eligible for endocrine therapy. Primary end points were objective response (OR), defined as complete (CR) or partial (PR) response, time to progression (TTP), and tolerability.Anastrozole was as effective as tamoxifen in terms of OR (21% v 17% of patients, respectively), with clinical benefit (CR + PR + stabilization > or = 24 weeks) observed in 59% of patients on anastrozole and 46% on tamoxifen (two-sided P =.0098, retrospective analysis). Anastrozole had a significant advantage over tamoxifen in terms of TTP (median TTP of 11.1 and 5.6 months for anastrozole and tamoxifen, respectively; two-sided P =.005). The tamoxifen:anastrozole hazards ratio was 1.44 (lower one-sided 95% confidence limit, 1.16). Both treatments were well tolerated. However, thromboembolic events and vaginal bleeding were reported in fewer patients who received anastrozole compared with those who received tamoxifen (4.1% v 8.2% [thromboembolic events] and 1.2% v 3.8% [vaginal bleeding], respectively).Anastrozole satisfied the predefined criteria for equivalence to tamoxifen. Furthermore, we observed both a significant increase in TTP and a lower incidence of thromboembolic events and vaginal bleeding with anastrozole. These findings indicate that anastrozole should be considered as first-line therapy for postmenopausal women with advanced breast cancer." @default.
• W1932574503 created "2016-06-24" @default.
• W1932574503 creator A5003654255 @default.
• W1932574503 creator A5005616347 @default.
• W1932574503 creator A5018170018 @default.
• W1932574503 creator A5040038139 @default.
• W1932574503 creator A5060027977 @default.
• W1932574503 creator A5068246195 @default.
• W1932574503 creator A5071158497 @default.
• W1932574503 creator A5072927466 @default.
• W1932574503 creator A5079958823 @default.
• W1932574503 date "2000-11-15" @default.
• W1932574503 modified "2023-10-09" @default.
• W1932574503 title "Anastrozole Is Superior to Tamoxifen as First-Line Therapy for Advanced Breast Cancer in Postmenopausal Women: Results of a North American Multicenter Randomized Trial" @default.
• W1932574503 cites W1262485082 @default.
• W1932574503 cites W1562190372 @default.
• W1932574503 cites W1810933484 @default.
• W1932574503 cites W1909697168 @default.
• W1932574503 cites W1934173384 @default.
• W1932574503 cites W1943320567 @default.
• W1932574503 cites W1974523663 @default.
• W1932574503 cites W1978054190 @default.
• W1932574503 cites W1994207027 @default.
• W1932574503 cites W1998867497 @default.
• W1932574503 cites W2002905683 @default.
• W1932574503 cites W2009772542 @default.
• W1932574503 cites W2013657890 @default.
• W1932574503 cites W2014328262 @default.
• W1932574503 cites W2018667612 @default.
• W1932574503 cites W2024793633 @default.
• W1932574503 cites W2057459166 @default.
• W1932574503 cites W2058681718 @default.
• W1932574503 cites W2077614287 @default.
• W1932574503 cites W2082382339 @default.
• W1932574503 cites W2120816980 @default.
• W1932574503 cites W2132846837 @default.
• W1932574503 cites W2137792512 @default.
• W1932574503 cites W2137960551 @default.
• W1932574503 cites W2141647078 @default.
• W1932574503 cites W2160776546 @default.
• W1932574503 cites W2164489340 @default.
• W1932574503 cites W2166631738 @default.
• W1932574503 cites W2169073956 @default.
• W1932574503 cites W2225973205 @default.
• W1932574503 cites W2248572116 @default.
• W1932574503 cites W2315368724 @default.
• W1932574503 cites W4243116045 @default.
• W1932574503 cites W4245899528 @default.
• W1932574503 cites W4300776185 @default.
• W1932574503 doi "https://doi.org/10.1200/jco.2000.18.22.3758" @default.
• W1932574503 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11078488" @default.
• W1932574503 hasPublicationYear "2000" @default.
• W1932574503 type Work @default.
• W1932574503 sameAs 1932574503 @default.
• W1932574503 citedByCount "921" @default.
• W1932574503 countsByYear W19325745032012 @default.
• W1932574503 countsByYear W19325745032013 @default.
• W1932574503 countsByYear W19325745032014 @default.
• W1932574503 countsByYear W19325745032015 @default.
• W1932574503 countsByYear W19325745032016 @default.
• W1932574503 countsByYear W19325745032017 @default.
• W1932574503 countsByYear W19325745032018 @default.
• W1932574503 countsByYear W19325745032019 @default.
• W1932574503 countsByYear W19325745032020 @default.
• W1932574503 countsByYear W19325745032021 @default.
• W1932574503 countsByYear W19325745032022 @default.
• W1932574503 countsByYear W19325745032023 @default.
• W1932574503 crossrefType "journal-article" @default.
• W1932574503 hasAuthorship W1932574503A5003654255 @default.
• W1932574503 hasAuthorship W1932574503A5005616347 @default.
• W1932574503 hasAuthorship W1932574503A5018170018 @default.
• W1932574503 hasAuthorship W1932574503A5040038139 @default.
• W1932574503 hasAuthorship W1932574503A5060027977 @default.
• W1932574503 hasAuthorship W1932574503A5068246195 @default.
• W1932574503 hasAuthorship W1932574503A5071158497 @default.
• W1932574503 hasAuthorship W1932574503A5072927466 @default.
• W1932574503 hasAuthorship W1932574503A5079958823 @default.
• W1932574503 hasConcept C121608353 @default.
• W1932574503 hasConcept C126322002 @default.
• W1932574503 hasConcept C143998085 @default.
• W1932574503 hasConcept C197934379 @default.
• W1932574503 hasConcept C2776215463 @default.
• W1932574503 hasConcept C2777176818 @default.
• W1932574503 hasConcept C2778375690 @default.
• W1932574503 hasConcept C29456083 @default.
• W1932574503 hasConcept C530470458 @default.
• W1932574503 hasConcept C71924100 @default.
• W1932574503 hasConceptScore W1932574503C121608353 @default.
• W1932574503 hasConceptScore W1932574503C126322002 @default.
• W1932574503 hasConceptScore W1932574503C143998085 @default.
• W1932574503 hasConceptScore W1932574503C197934379 @default.
• W1932574503 hasConceptScore W1932574503C2776215463 @default.
• W1932574503 hasConceptScore W1932574503C2777176818 @default.
• W1932574503 hasConceptScore W1932574503C2778375690 @default.
• W1932574503 hasConceptScore W1932574503C29456083 @default.
• W1932574503 hasConceptScore W1932574503C530470458 @default.
• W1932574503 hasConceptScore W1932574503C71924100 @default.
• W1932574503 hasIssue "22" @default.

• next